Panacea Life Sciences Holdings, Inc.
PLSH
Revenue
1.06M
▲95.95k▲9.99%
3 Months ChangeAssets
17.41M
▼-570.92k▼-3.17%
3 Months ChangeLiabilities
27.04M
▲760.16k▲2.89%
3 Months ChangeFree Cash Flow
-362.09k
▼-33.02k▼-10.03%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-05-16
Form 8-K
ID: 0001493152-24-020133
2024-05-07
Form 8-K
ID: 0001493152-24-018058
2024-05-06
Form 10-Q
ID: 0001493152-24-017858
2024-03-07
Form 8-K
ID: 0001493152-24-009173
2024-02-05
Form 8-K
ID: 0001493152-24-004908
2023-11-14
Form 10-Q
ID: 0001493152-23-041041
2023-10-05
Form 8-K
ID: 0001493152-23-036315
2023-10-02
Form 8-K
ID: 0001493152-23-034965
2023-08-15
Form 10-Q
ID: 0001493152-23-028898
2023-07-10
Form 8-K
ID: 0001493152-23-024087